All AbMole products are for research use only, cannot be used for human consumption.
Bromocriptine, an ergoline derivative, is a dopamine agonist that is used in the treatment of pituitary tumors, Parkinson's disease (PD), hyperprolactinaemia, neuroleptic malignant syndrome, and type 2 diabetes.
Neural Regen Res. 2024 May;19(5):1142-1149.
Bromocriptine protects perilesional spinal cord neurons from lipotoxicity after spinal cord injury
Bromocriptine Mesylate purchased from AbMole
| Molecular Weight | 750.7 |
| Formula | C32H40BrN5O5.CH4O3S |
| CAS Number | 22260-51-1 |
| Solubility (25°C) | DMSO ≥ 50 mg/mL |
| Storage | -20°C, protect from light, sealed |
[3] Christy M Weiland, et al. Bromocriptine mesylate (Cycloset) for type 2 diabetes mellitus
| Related Dopamine Receptor Products |
|---|
| AJ-76
AJ-76 ((+)-AJ 76; (1S,2R)-AJ 76) is a dopamine autoreceptor antagonist. |
| A-412997
A-412997 is a selective Dopamine D4 agonist with Ki values of 12 and 7.9 nM for the rat and human receptors. |
| SKF 81297
SKF 81297 is a potent and selective dopamine D1 receptor agonist. |
| GBR 12783
GBR 12783 is a specific, potent and selective dopamine uptake inhibitor that inhibits the [3H]dopamine uptake by rat and mice striatal synaptosomes with IC50s of 1.8 nM and 1.2 nM, respectively. |
| RMI-61140
RMI-61140 is an orally active neuroleptics. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
